
Kevin E. Weddington
Examiner (ID: 6966)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1205, 1629, 2899 |
| Total Applications | 3386 |
| Issued Applications | 2180 |
| Pending Applications | 434 |
| Abandoned Applications | 815 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 15/659184 | CALCIUM GLUCONATE SOLUTIONS IN FLEXIBLE CONTAINERS | Jul 24, 2017 | Abandoned |
Array
(
[id] => 12183939
[patent_doc_number] => 20180042876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'INHALATION FORMULATIONS OF TREPROSTINIL'
[patent_app_type] => utility
[patent_app_number] => 15/657933
[patent_app_country] => US
[patent_app_date] => 2017-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 15456
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15657933
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/657933 | Inhalation formulations of Treprostinil | Jul 23, 2017 | Issued |
Array
(
[id] => 13659045
[patent_doc_number] => 10159664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-25
[patent_title] => Pharmaceutical composition and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 15/636353
[patent_app_country] => US
[patent_app_date] => 2017-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5178
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15636353
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/636353 | Pharmaceutical composition and preparation method therefor | Jun 27, 2017 | Issued |
Array
(
[id] => 13714133
[patent_doc_number] => 20170368021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => MEDICATED PRODUCE
[patent_app_type] => utility
[patent_app_number] => 15/632574
[patent_app_country] => US
[patent_app_date] => 2017-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15632574
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/632574 | MEDICATED PRODUCE | Jun 25, 2017 | Abandoned |
Array
(
[id] => 13699709
[patent_doc_number] => 20170360809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => VASCULAR CALCIFICATION
[patent_app_type] => utility
[patent_app_number] => 15/624299
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15624299
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/624299 | Vascular calcification | Jun 14, 2017 | Issued |
Array
(
[id] => 11969838
[patent_doc_number] => 20170273992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR PREVENTING GLUCOCORTICOID-INDUCED CORNEAL OR SKIN THINNING'
[patent_app_type] => utility
[patent_app_number] => 15/616971
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5534
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15616971
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/616971 | Pharmaceutical compositions for preventing glucocorticoid-induced corneal thinning | Jun 7, 2017 | Issued |
Array
(
[id] => 12656635
[patent_doc_number] => 20180110711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => METHOD OF ENHANCING HAIR GROWTH
[patent_app_type] => utility
[patent_app_number] => 15/617739
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15617739
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/617739 | METHOD OF ENHANCING HAIR GROWTH | Jun 7, 2017 | Abandoned |
Array
(
[id] => 13687411
[patent_doc_number] => 20170354660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => Medical Use of Pharmaceutical Combination or Composition
[patent_app_type] => utility
[patent_app_number] => 15/616974
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15616974
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/616974 | Medical use of pharmaceutical combination or composition | Jun 7, 2017 | Issued |
Array
(
[id] => 14926107
[patent_doc_number] => 20190298691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => FLT3 RECEPTOR INHIBITOR AT LOW DOSAGE FOR THE TREATMENT OF NEUROPATHIC PAIN
[patent_app_type] => utility
[patent_app_number] => 16/307968
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307968
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307968 | FLT3 receptor inhibitor at low dosage for the treatment of neuropathic pain | Jun 7, 2017 | Issued |
Array
(
[id] => 11962134
[patent_doc_number] => 20170266287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases'
[patent_app_type] => utility
[patent_app_number] => 15/614592
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 55956
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15614592
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/614592 | Compositions and methods for treating chronic inflammation and inflammatory diseases | Jun 4, 2017 | Issued |
Array
(
[id] => 16523718
[patent_doc_number] => 20200397798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => COMBINATION THERAPIES WITH FARNESOID X RECEPTOR (FXR) MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/303741
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 127850
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303741 | COMBINATION THERAPIES WITH FARNESOID X RECEPTOR (FXR) MODULATORS | May 24, 2017 | Abandoned |
Array
(
[id] => 15524631
[patent_doc_number] => 20200054621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF POMALIDOMIDE
[patent_app_type] => utility
[patent_app_number] => 16/485959
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485959
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485959 | Pharmaceutical compositions of pomalidomide | May 16, 2017 | Issued |
Array
(
[id] => 14806089
[patent_doc_number] => 20190269654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => COMBINATION TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/302195
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302195
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302195 | Combination treatment of cancer | May 16, 2017 | Issued |
Array
(
[id] => 11947477
[patent_doc_number] => 20170251628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'PRE-FRONTAL CORTEX PROCESSING DISORDER SPEECH, GAIT AND LIMB IMPAIRMENTS TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/596075
[patent_app_country] => US
[patent_app_date] => 2017-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6723
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15596075
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/596075 | Pre-frontal cortex processing disorder speech, gait and limb impairments treatment | May 15, 2017 | Issued |
Array
(
[id] => 13729405
[patent_doc_number] => 20180369170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => METHOD OF TREATMENT WITH ANTI-INFLAMMATORY AND ANALGESIC COMPOUNDS WHICH ARE GI-, RENAL-, AND PLATELET-SPARING
[patent_app_type] => utility
[patent_app_number] => 15/594199
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15594199
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/594199 | Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing | May 11, 2017 | Issued |
Array
(
[id] => 15321559
[patent_doc_number] => 20200001109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => Methods For Treating Hyperbilirubinemia With Stannsoporfin And Phototherapy
[patent_app_type] => utility
[patent_app_number] => 16/300362
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300362
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300362 | Methods For Treating Hyperbilirubinemia With Stannsoporfin And Phototherapy | May 11, 2017 | Abandoned |
Array
(
[id] => 11992516
[patent_doc_number] => 20170296671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'Tamper Resistant Pharmaceutical Formulations'
[patent_app_type] => utility
[patent_app_number] => 15/588066
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10076
[patent_no_of_claims] => 150
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15588066
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/588066 | Tamper resistant pharmaceutical formulations | May 4, 2017 | Issued |
Array
(
[id] => 14516745
[patent_doc_number] => 10335608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Photodynamic compounds and methods for activating them using ionizing radiation and/or other electromagnetic radiation for therapy and/or diagnostics
[patent_app_type] => utility
[patent_app_number] => 15/492801
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 12
[patent_no_of_words] => 13031
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492801
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/492801 | Photodynamic compounds and methods for activating them using ionizing radiation and/or other electromagnetic radiation for therapy and/or diagnostics | Apr 19, 2017 | Issued |
Array
(
[id] => 14800327
[patent_doc_number] => 10403170
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Methods of treating overweight and obesity
[patent_app_type] => utility
[patent_app_number] => 15/491870
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16736
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15491870
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/491870 | Methods of treating overweight and obesity | Apr 18, 2017 | Issued |
Array
(
[id] => 14055373
[patent_doc_number] => 10231963
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => Methods for treating depressive symptoms
[patent_app_type] => utility
[patent_app_number] => 15/489377
[patent_app_country] => US
[patent_app_date] => 2017-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16042
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15489377
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/489377 | Methods for treating depressive symptoms | Apr 16, 2017 | Issued |